TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 20842418

Group type: EXPERIMENTAL
Intervention: ICSI
Number of subjects: 0

Group type: COMPARATOR
Intervention: IVF
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HA-binding assay
Number of subjects: 0
Study: 17952411

Group type: EXPERIMENTAL
Intervention: 0.8 g/kg glycine
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 16759769

Group type: EXPERIMENTAL
Intervention: Combined DTaP-IPV vaccine
Number of subjects: 400

Group type: COMPARATOR
Intervention: Separate DTaP and IPV vaccines
Number of subjects: 400
Study: 14673985

Group type: EXPERIMENTAL
Intervention: Conventional radiography
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Ultrasound
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: MRI
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Dynamic contrast-enhanced MRI
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group (10 patients with shoulder pain)
Number of subjects: 43
Study: 10964860

Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 410

Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 410

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 410
Study: 8981527

Group type: EXPERIMENTAL
Intervention: rHuEPO administered subcutaneously three times weekly (group A)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: rHuEPO administered subcutaneously once weekly (group B)
Number of subjects: 33
Study: 1282586

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Diltiazem
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 4051273

Group type: EXPERIMENTAL
Intervention: Solution A (tetracaine 0.5%, adrenalin 1:2,000, cocaine 11.8%)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Solution B (tetracaine 0.5%, adrenalin 1:2,000, no cocaine)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Solution A
Number of subjects: 0

Group type: COMPARATOR
Intervention: Solution B
Number of subjects: 0
Study: 31087556

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 120

Group type: COMPARATOR
Intervention: Re-analysis of data from 95 cases
Number of subjects: 120
Study: 29102571

Group type: EXPERIMENTAL
Intervention: Clopidogrel
Number of subjects: 1815

Group type: COMPARATOR
Intervention: Alternative therapy (prasugrel, ticagrelor)
Number of subjects: 1815
Study: 27066777

Group type: EXPERIMENTAL
Intervention: Simplified verbal and written summaries of trial information
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Trial information provided during antenatal period (suggested by women)
Number of subjects: 49
Study: 24656562

Group type: EXPERIMENTAL
Intervention: IUI with ovarian stimulation
Number of subjects: 65

Group type: COMPARATOR
Intervention: IUI without ovarian stimulation followed by IUI with ovarian stimulation
Number of subjects: 65

Group type: COMPARATOR
Intervention: IUI with natural/ovarian stimulation
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Preceding long-term pituitary down-regulation
Number of subjects: 65
Study: 22295826

Group type: EXPERIMENTAL
Intervention: Sanyinjiao (SP 6) acupuncture
Number of subjects: 16

Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 16
Study: 20141300

Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy (MBCT) plus treatment as usual (TAU)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 27
Study: 18698140

Group type: EXPERIMENTAL
Intervention: Voxel-based morphometry
Number of subjects: 50
Study: 15842294

Group type: EXPERIMENTAL
Intervention: Proportions of agreement
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Kappa for categorical variables
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Limits of agreement
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intraclass correlation coefficient for continuous variables
Number of subjects: 0
Study: 11865422

Group type: EXPERIMENTAL
Intervention: Cerebrospinal fluid (CSF) levels of quinolinic acid (QA)
Number of subjects: 261

Group type: EXPERIMENTAL
Intervention: Cerebrospinal fluid (CSF) levels of picolinic acid (PA)
Number of subjects: 261

Group type: EXPERIMENTAL
Intervention: Cerebrospinal fluid (CSF) levels of kynurenic acid (KA)
Number of subjects: 261

Group type: EXPERIMENTAL
Intervention: Cerebrospinal fluid (CSF) lactate levels
Number of subjects: 261

Group type: EXPERIMENTAL
Intervention: Cerebrospinal fluid (CSF) levels of QA and PA
Number of subjects: 261
Study: 10190653

Group type: EXPERIMENTAL
Intervention: Fosinopril (10 mg-20 mg daily)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 7759741

Group type: EXPERIMENTAL
Intervention: High-intensity exercise (80% VO2max)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Low-intensity exercise (50% VO2max)
Number of subjects: 12
Study: 2083097

Group type: EXPERIMENTAL
Intervention: Curosurf (200 mg/kg) via the tracheal tube
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (8 infants)
Number of subjects: 10
Study: 359248

Group type: EXPERIMENTAL
Intervention: 500 mg diflunisal twice daily
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: 65 mg dextropropoxyphene plus 650 mg paracetamol 3-times daily
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study: 31623851

Group type: EXPERIMENTAL
Intervention: Self condition - children waited to eat their food item to receive a second food item.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prosocial condition - children waited to eat their food item to benefit another child.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonsocial Control condition - children waited to eat their food item with no benefit to anyone.
Number of subjects: 0
Study: 31613825

Group type: EXPERIMENTAL
Intervention: Endogenous estrogen exposure (EEE)
Number of subjects: 2114

Group type: EXPERIMENTAL
Intervention: Hormone therapy (HT) duration
Number of subjects: 2114

Group type: EXPERIMENTAL
Intervention: Timing of HT initiation (within 5 years of menopause)
Number of subjects: 2114
Study: 28658104

Group type: EXPERIMENTAL
Intervention: High resolution magnetic resonance cholangiopancreatography (HR‐MRCP) and T 2 ‐weighted imaging (HR‐T 2 WI)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Catheter withdrawal
Number of subjects: 41
Study: 26005742

Group type: EXPERIMENTAL
Intervention: Training video
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo video
Number of subjects: 75
Study: 23043512

Group type: EXPERIMENTAL
Intervention: Sevoflurane anesthesia combined with caudal block
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Desflurane anesthesia combined with caudal block
Number of subjects: 260

Group type: COMPARATOR
Intervention: Sevoflurane anesthesia
Number of subjects: 260

Group type: COMPARATOR
Intervention: Desflurane anesthesia
Number of subjects: 260
Study: 22187760

Group type: EXPERIMENTAL
Intervention: Prophylactic intramuscular ephedrine 0.5 mg/kg given 10 minutes before spinal anaesthesia
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Prophylactic intramuscular ephedrine 0.5 mg/kg given 20 minutes before spinal anaesthesia
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group (Group C) received only preloading with 15 ml/kg of Ringer lactate solution
Number of subjects: 150
Study: 19101227

Group type: EXPERIMENTAL
Intervention: Increase in HDL cholesterol
Number of subjects: 3020

Group type: EXPERIMENTAL
Intervention: Decrease in triglycerides
Number of subjects: 3020

Group type: EXPERIMENTAL
Intervention: Decrease in LDL cholesterol
Number of subjects: 3020
Study: 16304565

Group type: EXPERIMENTAL
Intervention: 6-Min Walk Test (6MWT)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: 10-Meter Walk Test (10MWT)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Walking Index for Spinal Cord Injury II (WISCI II)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Lower Extremity Motor Score (LEMS)
Number of subjects: 22
Study: 15277912

Group type: EXPERIMENTAL
Intervention: BIS monitoring
Number of subjects: 1380

Group type: COMPARATOR
Intervention: Standard practice
Number of subjects: 1380
Study: 11488779

Group type: EXPERIMENTAL
Intervention: Ebastine 60 mg/day
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Ebastine 100 mg/day
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Terfenadine 360 mg/day
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 9669009

Group type: EXPERIMENTAL
Intervention: bupivacaine 0.5% 38 ml + 10 mg midazolam (Group M10)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: bupivacaine 0.5% 36 ml + 20 mg midazolam (Group M20)
Number of subjects: 60

Group type: COMPARATOR
Intervention: bupivacaine 0.5% (Group C)
Number of subjects: 60
Study: 8049691

Group type: EXPERIMENTAL
Intervention: diazepam 5 mg + glycopyrrolate 300 micrograms
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: diazepam 5 mg + atropine 600 micrograms
Number of subjects: 190

Group type: COMPARATOR
Intervention: diazepam 5 mg
Number of subjects: 190
Study: 3291657

Group type: COMPARATOR
Intervention: Radiation alone (167 patients)
Number of subjects: 326

Group type: EXPERIMENTAL
Intervention: Radiation followed by 6 cycles of MOPP chemotherapy (159 patients)
Number of subjects: 326

Group type: EXPERIMENTAL
Intervention: MOPP chemotherapy
Number of subjects: 326

Group type: EXPERIMENTAL
Intervention: Overall population (both groups)
Number of subjects: 326
Study: 31189670

Group type: EXPERIMENTAL
Intervention: Products labelled with 0%ABV or verbal descriptors Low or Super Low
Number of subjects: 3390

Group type: COMPARATOR
Intervention: Products labelled with higher %ABV
Number of subjects: 3390
Study: 27431584

Group type: EXPERIMENTAL
Intervention: Shared care (n=45)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Usual care (n=43)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Shared care
Number of subjects: 88

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 88
Study: 25380222

Group type: EXPERIMENTAL
Intervention: Individualized guided internet-delivered cognitive-behavioral therapy for 8 weeks
Number of subjects: 52

Group type: COMPARATOR
Intervention: Moderated online discussion forum (control group)
Number of subjects: 52
Study: 23415123

Group type: EXPERIMENTAL
Intervention: Computer-assisted guidance in electronic patient record
Number of subjects: 0
Study: 22018150

Group type: EXPERIMENTAL
Intervention: Varicocele group
Number of subjects: 190

Group type: COMPARATOR
Intervention: Control group (normozoospermic men, n=100)
Number of subjects: 190
Study: 19614942

Group type: EXPERIMENTAL
Intervention: Vildagliptin (100 mg)
Number of subjects: 2478

Group type: COMPARATOR
Intervention: Thiazolidinediones (TZD)
Number of subjects: 2478

Group type: EXPERIMENTAL
Intervention: Vildagliptin
Number of subjects: 2478
Study: 17199098

Group type: EXPERIMENTAL
Intervention: Caffeine (400 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 14628981

Group type: EXPERIMENTAL
Intervention: Modafinil (100-400 mg once daily)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 136
Study: 11042786

Group type: EXPERIMENTAL
Intervention: Lecturer practitioners
Number of subjects: 117

Group type: COMPARATOR
Intervention: University‐based senior lecturers
Number of subjects: 117
Study: 9138543

Group type: EXPERIMENTAL
Intervention: Clonidine (2 micrograms x kg‐1)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Pethidine (0.3 mg x kg‐1)
Number of subjects: 60

Group type: COMPARATOR
Intervention: 0.9% saline (control)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 60
Study: 8346761

Group type: EXPERIMENTAL
Intervention: Strength Shoe training regimen
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Plyometrics in a properly supervised setting
Number of subjects: 0
Study: 3525615

Group type: EXPERIMENTAL
Intervention: Carbamazepine treatment
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 31969566

Group type: EXPERIMENTAL
Intervention: n‐3 long‐chain fatty acids and vitamin D supplementation
Number of subjects: 695
Study: 29471478

Group type: EXPERIMENTAL
Intervention: Internet-delivered Cognitive-Behavioral Therapy for Insomnia (iCBT-I)
Number of subjects: 255

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 255
Study: 28592518

Group type: EXPERIMENTAL
Intervention: Zinc supplementation (9 mg elemental Zn/d for 4 weeks)
Number of subjects: 147

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 147
Study: 26408730

Group type: COMPARATOR
Intervention: 5-FU alone
Number of subjects: 855

Group type: EXPERIMENTAL
Intervention: 5-FU plus folinic acid (FA)
Number of subjects: 855

Group type: EXPERIMENTAL
Intervention: 5-FU plus interferon-alpha (IFNa)
Number of subjects: 855
Study: 24187098

Group type: EXPERIMENTAL
Intervention: Pharmacist-initiated multidisciplinary intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Health Utilities Index mark 3 (HUI3)
Number of subjects: 0
Study: 21440562

Group type: EXPERIMENTAL
Intervention: Anodal transcranial direct current stimulation (tDCS)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Transcranial random noise stimulation (tRNS)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 60
Study: 18241355

Group type: EXPERIMENTAL
Intervention: Pulsed electrical stimulation (E-PES)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 16632830

Group type: EXPERIMENTAL
Intervention: Laparoscopic myomectomy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Laparotomy
Number of subjects: 40
Study: 12610815

Group type: EXPERIMENTAL
Intervention: BAY 12‐9566 (100 mg)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 10593462

Group type: EXPERIMENTAL
Intervention: Forced air warming
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control (no forced air warming)
Number of subjects: 50
Study: 8709213

Group type: EXPERIMENTAL
Intervention: Zidovudine (AZT) monotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: AZT plus 2',3'-dideoxyinosine (ddI) combination therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: AZT plus 2',3'-dideoxycytidine (ddC) combination therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: AZT monotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination therapy (AZT + ddI or AZT + ddC)
Number of subjects: 0
Study: 1682734

Group type: EXPERIMENTAL
Intervention: Aspirin 75 mg daily
Number of subjects: 1360

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1360
Study: 7036960

Group type: EXPERIMENTAL
Intervention: Antacid (hourly)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Cimetidine (1 g/day)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 94
Study: 30579406

Group type: EXPERIMENTAL
Intervention: SPOC scores at 6 weeks post-surgery
Number of subjects: 1218
Study: 28488610

Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Lamotrigine
Number of subjects: 30
Study: 27142859

Group type: EXPERIMENTAL
Intervention: Competencies identified in round 1 of the survey
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Competencies identified in round 2 of the survey
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Competencies rated most important
Number of subjects: 158
Study: 25127289

Group type: EXPERIMENTAL
Intervention: Interactive skills-building groups
Number of subjects: 152

Group type: COMPARATOR
Intervention: Didactic psychoeducational groups
Number of subjects: 152
Study: 22535269

Group type: EXPERIMENTAL
Intervention: Active treatment (perindopril +/‐ indapamide)
Number of subjects: 6105

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6105
Study: 19433070

Group type: EXPERIMENTAL
Intervention: Chlorpyrifos oxon (CPO) detection using a newly developed enzyme‐based assay
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Pralidoxime regimen
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Clinical outcomes and response to antidotes
Number of subjects: 74
Study: 18042521

Group type: EXPERIMENTAL
Intervention: Dietary plant sterols (2 g/day)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 10942860

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Medical devices
Number of subjects: 0
Study: 9506785

Group type: EXPERIMENTAL
Intervention: Biventricular (ECMO) support
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Uni- (LVAD) support
Number of subjects: 6

Group type: COMPARATOR
Intervention: ECMO support
Number of subjects: 6

Group type: COMPARATOR
Intervention: LVAD support
Number of subjects: 6
Study: 8477404

Group type: EXPERIMENTAL
Intervention: Experimental intervention aimed at maintaining or restoring attentional capacity
Number of subjects: 32

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 32
Study: 3773181

Group type: EXPERIMENTAL
Intervention: Drug information sheet
Number of subjects: 71
Study: 29461858

Group type: EXPERIMENTAL
Intervention: Three-minute finger-tip point massage of Neiguan, Juque, and Xinshu acupoints with sticky capsaicin-dressed heat plasters
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo acupressure
Number of subjects: 40
Study: 27816052

Group type: EXPERIMENTAL
Intervention: n-3 (ω3) meal (DHA=500 mg; fish oil)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Saturated fat meal (16 g; coconut oil)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: n-6 (ω6) meal (7.4 g; grapeseed oil)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control meal (20% fat; olive oil)
Number of subjects: 20
Study: 24739218

Group type: EXPERIMENTAL
Intervention: Physical-Social Functioning (PSF)
Number of subjects: 2281

Group type: EXPERIMENTAL
Intervention: Emotional Functioning (EF)
Number of subjects: 2281

Group type: COMPARATOR
Intervention: High Emotional Functioning (EF)
Number of subjects: 2281

Group type: EXPERIMENTAL
Intervention: Predictors of high EF trajectories
Number of subjects: 2281
Study: 22519895

Group type: EXPERIMENTAL
Intervention: CXE closed circuit breathing system
Number of subjects: 6

Group type: COMPARATOR
Intervention: Open circuit breathing system
Number of subjects: 6
Study: 19943881

Group type: EXPERIMENTAL
Intervention: Fondaparinux 2.5 mg day(-1)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Enoxaparin 1 mg kg(-1) twice daily
Number of subjects: 90
Study: 18179457

Group type: EXPERIMENTAL
Intervention: Sildenafil citrate
Number of subjects: 354

Group type: EXPERIMENTAL
Intervention: Penile implants
Number of subjects: 354

Group type: EXPERIMENTAL
Intervention: Testosterone
Number of subjects: 354

Group type: EXPERIMENTAL
Intervention: Satisfied cases
Number of subjects: 354

Group type: EXPERIMENTAL
Intervention: Dissatisfied cases
Number of subjects: 354
Study: 15876898

Group type: EXPERIMENTAL
Intervention: Topiramate (n = 25)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo (n = 18)
Number of subjects: 43
Study: 12642046

Group type: EXPERIMENTAL
Intervention: Azithromycin (500 mg on the first day, followed by 250 mg daily for 4 days)
Number of subjects: 1439

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1439

Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 1439
Study: 10754944

Group type: EXPERIMENTAL
Intervention: Once and twice daily valaciclovir or aciclovir
Number of subjects: 1479

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1479
Study: 8873165

Group type: EXPERIMENTAL
Intervention: Borg 15‐category Ratings of Perceived Exertion (RPE) scale during semirecumbent exercise
Number of subjects: 9
Study: 1951212

Group type: EXPERIMENTAL
Intervention: Intravenous immune globulin (IVIG) 750 mg/kg administered within 72 hours of admission and every 14 days until discharge or age 3 months.
Number of subjects: 170

Group type: COMPARATOR
Intervention: Placebo (albumin) administered within 72 hours of admission and every 14 days until discharge or age 3 months.
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Intravenous immune globulin (IVIG)
Number of subjects: 170
Study: 30236118

Group type: EXPERIMENTAL
Intervention: Low THC and no CBD cannabis variant
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Low THC and high CBD cannabis variant
Number of subjects: 12

Group type: COMPARATOR
Intervention: High-potency cannabis (HPC)
Number of subjects: 12
Study: 26547109

Group type: EXPERIMENTAL
Intervention: 70 mg brodalumab
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 140 mg brodalumab
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 210 mg brodalumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 24793252

Group type: EXPERIMENTAL
Intervention: Text messaging reminders for influenza vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 0
Study: 22375571

Group type: EXPERIMENTAL
Intervention: Team Resilience (TR) training program
Number of subjects: 947

Group type: COMPARATOR
Intervention: Control group (workers in control stores)
Number of subjects: 947
Study: 20195589

Group type: EXPERIMENTAL
Intervention: Salbutamol via pressurized metered-dose inhaler with spacer (50 microg/kg)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Salbutamol via nebulization (150 microg/kg)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Age group >2 years
Number of subjects: 46

Group type: COMPARATOR
Intervention: Age group <=2 years
Number of subjects: 46
Study: 18639603

Group type: EXPERIMENTAL
Intervention: Third-generation electrically heated cigarette smoking system (EHCSS)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional cigarette (CC)
Number of subjects: 60

Group type: COMPARATOR
Intervention: No-smoking
Number of subjects: 60
Study: 16154678

Group type: EXPERIMENTAL
Intervention: Video-based self-instruction (VSI) program (22-min video, inflatable training manikin, audio prompting device)
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: Video-based self-instruction (VSI) program
Number of subjects: 285

Group type: COMPARATOR
Intervention: Heartsaver training
Number of subjects: 285

Group type: COMPARATOR
Intervention: Untrained control group
Number of subjects: 285
Study: 12927002

Group type: EXPERIMENTAL
Intervention: mirtazapine (15 mg daily increased to 30 mg daily after 1 week)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: mirtazapine
Number of subjects: 50

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 50